about
Is the prevalence of overactive bladder overestimated? A population-based study in FinlandInhibition of the cation channel TRPV4 improves bladder function in mice and rats with cyclophosphamide-induced cystitisNeural mechanisms underlying lower urinary tract dysfunctionA healthy bladder: a consensus statementOveractive bladder syndrome and the potential role of prostaglandins and phosphodiesterases: an introductionTrospium chloride treatment of overactive bladderUrodynamic properties and neurotransmitter dependence of urinary bladder contractility in the BK channel deletion model of overactive bladderInducible knockout mutagenesis reveals compensatory mechanisms elicited by constitutive BK channel deficiency in overactive murine bladder.Correlation between overactive bladder symptom score and neuropsychological parameters in Alzheimer's disease patients with lower urinary tract symptom.Bladder Transplantation of Amniotic Fluid Stem Cell may Ameliorate Bladder Dysfunction After Focal Cerebral Ischemia in RatAltered detrusor gap junction communications induce storage symptoms in bladder inflammation: a mouse cyclophosphamide-induced model of cystitis.The effect of medication use on urinary incontinence in community-dwelling elderly women.Dose and aging effect on patients reported treatment benefit switching from the first overactive bladder therapy with tolterodine ER to fesoterodine: post-hoc analysis from an observational and retrospective studyPopulation based study of incidence and predictors of urinary incontinence in black and white older adults.Predictors of urinary incontinence in community-dwelling frail older adults with diabetes mellitus in a cross-sectional studyPharmacodynamics of propiverine and three of its main metabolites on detrusor contractionOveractive bladder in malesIntravesical resiniferatoxin for the treatment of storage lower urinary tract symptoms in patients with either interstitial cystitis or detrusor overactivity: a meta-analysis.Influence of estradiol on micturition thresholds in the rat: involvement of the hypogastric nerve.α1-Adrenoceptors and muscarinic receptors in voiding function - binding characteristics of therapeutic agents in relation to the pharmacokinetics.Diabetes mellitus performance measures in individuals with limited life expectancyDo the urinary bladder and large bowel interact, in sickness or in health? ICI-RS 2011.PATTERN OF OVERACTIVE BLADDER IN SOUTHEAST NIGERIA.Mirabegron: a Beta-3 agonist for overactive bladder.Classification of nocturia in the adult and elderly patient: a review of clinical criteria and selected literature.Nocturia in relation to sleep, health, and medical treatment in the elderly.Dual use of bladder anticholinergics and cholinesterase inhibitors: long-term functional and cognitive outcomes.The CNS and bladder dysfunctionDiagnosis and management of patients with overactive bladder syndrome and abnormal detrusor activity.The overactive bladder: review of current pharmacotherapy in adults. Part 1: pathophysiology and anticholinergic therapy.The overactive bladder: review of current pharmacotherapy in adults. Part 2: treatment options in cases refractory to anticholinergics.AMPK Suppresses Connexin43 Expression in the Bladder and Ameliorates Voiding Dysfunction in Cyclophosphamide-induced Mouse Cystitis.Pharmacologic treatment for urgency-predominant urinary incontinence in women diagnosed using a simplified algorithm: a randomized trialAntihypertensive drug class use and differential risk of urinary incontinence in community-dwelling older women.A review of solifenacin in the treatment of urinary incontinence.Overactive bladder treatments in early phase clinical trials.Agents for treatment of overactive bladder: a therapeutic class review.Changing concepts of bladder regeneration.Initial experience with sacral neuromodulation for the treatment of lower urinary tract dysfunction in BrazilPharmacologic management of overactive bladder.
P2860
Q21144463-2F066D1A-40E3-4012-8F3D-A01D216C679FQ24614844-CEF50FEB-6CF9-4011-8B63-C44CA01542DFQ26852088-528F66F5-00A9-4699-93AA-796E70097076Q26863299-D2D749A2-F0F1-482C-9772-2192B6425C4BQ27011502-7FCCEEF9-78DE-445A-AF30-371827B646C7Q28308162-DFD53531-BDBC-416D-B82B-CEDF3A1F5953Q28505033-47F19ECB-5189-4942-918A-5E3744BB4066Q33630889-55AE9358-414F-4B84-83B7-4C3201BDA8C6Q33692634-F9F044CE-7FCB-4328-BC87-171CA8B24FB6Q33722600-000DA254-F965-47C3-AD7B-EE5F92A2BDE1Q34010976-FBC9AE71-032D-4F4A-9DFA-B03A59ECBF08Q34154809-E09EE3DF-E768-48D3-8B9E-10BC8F3F0FB1Q34352604-08E79651-39AC-42C4-B43D-3BB3A6B4DD1CQ34392469-E153F0B5-D319-49FB-8D86-5A02F6AF437AQ34762194-7F2C896D-39D6-46E8-905E-7376E31D912EQ35048983-D9E50095-7251-421D-9B98-32838ED2E6F1Q35076391-391C756F-5CD9-4567-A09F-5FEA63B73DD1Q35077636-F0B7D74C-5BEA-48FF-8129-A96F39ED3962Q35126971-8284104B-7607-4067-A787-F620FFE1BE59Q35183611-2E99F464-3268-49ED-8390-E160D28AEF93Q35762744-84E9416C-2316-43AB-B83A-5A6E32E3BA76Q35842916-2248E148-89B6-405A-99DC-2272D38CA508Q36006372-2AFCE831-9FD4-41A8-9BB8-671FAF385978Q36160960-1ED394F8-DFA6-4EED-AD06-B60CF5360105Q36219823-CF362732-FE22-4B51-9151-DAD353AA874DQ36219827-7F5D1279-BBBA-4BA6-822C-F49F3AA2EC23Q36283014-FBCC2EC9-2255-41B7-8CC1-DE931CD4A0A6Q36314727-E17CB9D9-B319-4801-8958-E58E72A99D4FQ36395035-86BFB1AD-6460-463D-A7AA-6DE8414D38DBQ36428471-65989CFA-35B3-4FE0-B211-6F23E7583297Q36428476-B26E381A-7F18-4883-B83C-C494C1263880Q36500671-CC678BC2-DF29-4CFC-8894-E6E60F196575Q36603287-16ADE2E8-A72F-4CFF-96C2-1180CD32EA66Q36796198-88C1F1A1-E2A4-4E36-85E7-584EA43343F2Q36822864-28062645-3AA3-41B7-A82E-B3D45D95DE80Q36861588-ECEA24D3-5E5F-4038-97AF-1B873A7F7542Q36885443-243E4A8A-E3C2-4B73-ADE2-1A70ED8A3D85Q36903113-89D3D7D7-850A-45FB-9982-1BA6CFCC1CC7Q36912787-0C526145-1F60-4D10-9653-C122635F8A75Q37017434-5E8D8953-A81C-43E1-A083-178036B8DA08
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Management of overactive bladder.
@ast
Management of overactive bladder.
@en
type
label
Management of overactive bladder.
@ast
Management of overactive bladder.
@en
prefLabel
Management of overactive bladder.
@ast
Management of overactive bladder.
@en
P356
P1476
Management of overactive bladder.
@en
P2093
Joseph G Ouslander
P304
P356
10.1056/NEJMRA032662
P407
P577
2004-02-01T00:00:00Z